New oral combo aims to keep devastating blood cancer at bay
NCT ID NCT07463768
Summary
This study is testing whether taking two oral medications, ivosidenib and azacitidine, can help keep a specific type of acute myeloid leukemia (AML) from coming back in older adults. It is for patients aged 55+ who have achieved remission after intensive chemotherapy and have a specific genetic change called an IDH1 mutation. The main goal is to see if this maintenance therapy can help patients stay in remission longer without the need for a stem cell transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH côte Basque
Bayonne, 64109, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CH de Perpignan
Perpignan, 66046, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHRU Nancy
Vandœuvre-lès-Nancy, 54500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Angers
Angers, 49933, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Besançon
Besançon, 25030, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Grenoble
Grenoble, 38043, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Henri Mondor
Créteil, 94000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Limoges
Limoges, 87000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nantes
Nantes, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nîmes - Institut de Cancérologie du Gard
Nîmes, 30029, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de TOULOUSE - IUCT ONCOPOLE
Toulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Henri Becquerel
Rouen, 76038, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chru Bretonneau
Tours, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chru de Lille - Hopital Claude Huriez
Lille, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu de Rennes - Hopital Pontchaillou
Rennes, 35033, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Gustave Roussy
Villejuif, 94800, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hopital d'Instruction des Armées Percy
Clamart, 92140, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Haut-Lévêque
Pessac, 33604, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Lyon-Sud
Pierre-Bénite, 69310, France
-
Hôpital Saint Louis
Paris, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.